Cardiovascular Disease in Women Module IX: Presentation Resources and Internet Resources This slide set was updated April 2008.

Slides:



Advertisements
Similar presentations
Part 2: Recommendations for Hypertension Treatment
Advertisements

Advance your career – Council on Lifestyle and Cardiometabolic Health Promotes expansion and exchange of knowledge on nutrition, physical activity, obesity.
NCEP ATP IV GuidelineS: 2013 Update
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women.
National Service Framework for diabetes Ruth BarnesMina Fernando Director of Public HealthDiabetes Manager.
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
Produced by The Alfred Workforce Development Team on behalf of DHS Public Health - Diabetes Prevention and Management Initiative June 2005 Diabetes Prevention.
SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.
Innovative Pharmacy Services Jann B. Skelton, RPh, MBA Vice President of Operations MEDICA.
Slide Source: Lipids Online Slide Library CDC/AHA Scientific Statement on Inflammatory Markers and Cardiovascular Disease: Recommendations.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
1 Women & Heart Disease Julia C. Orri, Ph.D. Biol. 330 November 21, 2006.
1 Obesity Treatment in Special Populations Smokers –All smokers, regardless of weight, should quit smoking. –Implement weight gain prevention, treatment.
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
DYSLIPIDEMIA IN ADULTS WITH DIABETES* 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada *Updated in Leiter.
Healthy People 2010 Focus Area 12: Heart Disease and Stroke
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Lifestyle Medicine 101 Presented by ACLM Professionals in Training Executive Board 2014.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Risk estimation and the prevention of cardiovascular disease SIGN 97.
Cardiovascular Disease in Women Module I: Epidemiology.
Evidence-based Checkup for Patient Education Web Sites Suzanne Austin Boren, MHA Center for Health Care Quality University of Missouri
European Society of Cardiology Cardiovascular diseases in women.
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
“Growing Healthy Kids III” Weight-Related Assessment and Management Tools for Youth Maria G. Boosalis, Ph.D., MPH, R.D., L.D. University of Kentucky Division.
The Renin-Angiotensin- Aldosterone System: Linking New Data and Mechanisms for Cardiovascular Risk Reduction VBWG.
Evidence-Based Medicine – Definitions and Applications 1 Component 2 / Unit 5 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
Comparison of two cardiovascular risk assessment tools to determine appropriate use of aspirin as primary prevention for patients with type 2 diabetes.
Introduction to Healthcare and Public Health in the US The Evolution and Reform of Healthcare in the US Lecture b This material (Comp1_Unit9b) was developed.
New Guidelines for Myocardial Ischemia Management.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
Using QOF and Service Specifications to meet HI Needs Rachel Foskett-Tharby.
Module 3: Alzheimer’s Disease – What is the Role of Public Health? A Public Health Approach to Alzheimer’s and Other Dementias.
References 1.Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement.
Findings suggest: Improvement was noted in both BMI and reported physical activity although the differences did not reach statistical difference. Behavior.
Department of Public Health Presentation to the Health Cabinet June 14, 2016.
A PUBLIC HEALTH APPROACH TO ALZHEIMER’S AND OTHER DEMENTIAS ALZHEIMER’S DISEASE – WHAT IS THE ROLE OF PUBLIC HEALTH?
by , Rita F. Redberg, Emelia J. Benjamin, Vera Bittner, Lynne T
1Concepts of Physical Fitness 6e Presentation Package for Concepts of Fitness and Wellness 6e Section II: Concept 04 The Health Benefits of Physical Activity.
T.Vasilopoulos1, C.Tatsi1, C. Lionis1
Hypertension guidelines What’s all the controversy about 2015
Copyright © 2017 American Academy of Pediatrics.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Diabetes Health Status Report
Achieving the Clinical Potential of RAAS Blockade
AIM-HIGH Niacin Plus Statin to Prevent Vascular Events
Nat. Rev. Nephrol. doi: /nrneph
اتجاهات أنماط المرض بين السكان. المراحل الأربع للتحول الوبائى.
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
The 50% Myth: Do we need new cardiovascular risk factors?
Section 9: Continuum of care: Summary and timeline
Section III: Neurohormonal strategies in heart failure
Depicted are patient and disease factors used to determine optimal A1C targets. Depicted are patient and disease factors used to determine optimal A1C.
The relations of lifestyle, established and novel risk factors, and cardiovascular disease The relations of lifestyle, established and novel risk factors,
Relative risks of clinical events for primary and secondary prevention with selected drugs Thomas A Gaziano, et al. Lancet 2006; 368:
Estimated HR as a function of absolute change in glycated hemoglobin (HbA1c; from index to measurement 22–26 months after). Estimated HR as a function.
Intensity of statin treatment and possible lipid lowering treatment intolerance and/or ineffectiveness issues among patients with type 2 diabetes (aged.
Effects of Pay-for-Performance on the Quality of Primary Care in England Mean Scores for Clinical Quality at the Practice Level for Aspects of Care for.
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Component 1: Introduction to Health Care and Public Health in the U.S.
Estimated HR as a function of mean residual of glycated hemoglobin (HbA1c) measurements to the line connecting index HbA1c and HbA1c measurement 22–26 months.
The Heart Truth Delaware Background
Preventative Cardiology
Requested Information by CMS Team During April 30th Hearing
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Meta-analysis of trials examining the effects of aspirin on risk of CVD events in patients with diabetes. Meta-analysis of trials examining the effects.
Section 6: Update on lipid treatment guidelines
Presentation transcript:

Cardiovascular Disease in Women Module IX: Presentation Resources and Internet Resources This slide set was updated April 2008.

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

Objectives To present strategies to assess and stratify women into high risk, at risk, and optimal risk categories for cardiovascular disease To summarize lifestyle approaches to the prevention of cardiovascular disease in women

Objectives To review evidence-based approaches to cardiovascular disease prevention for patients with hypertension, lipid abnormalities, and diabetes To review an evidence-based approach to pharmacological risk intervention for women at risk for cardiovascular events

Objectives To summarize commonly used therapies that should not be initiated for the prevention or treatment of heart disease, because they lack benefit, or because risks outweigh benefits

The Heart Truth Professional Education Campaign Website http://www.womenshealth.gov/hearttruth Information for healthcare providers, including links to resources discussed in this presentation, are available at this site. Also included are links to web-based CME, and resources for health care professional educators, including slide sets and problem-based learning and standardized patient cases.

The Heart Truth Delaware Website http://www.hearttruthdelaware.org

Internet Resources: Smoking Cessation http://www.surgeongeneral.gov/tobacco/ treating_tobacco_use.pdf SLIDE INFORMATION SOURCE: Mosca L, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109:672-693. Source: Mosca 2004

Internet Resources: Mercury Levels in Seafood Species http://www.cfsan.fda.gov/~frf/sea-mehg.html Source: US EPA, DHHS

Internet Resources: Clinical Guidelines on Obesity Treatment http://www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm SLIDE INFORMATION SOURCE: Mosca L, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109:672-693. Source: Mosca 2004

Internet Resources: JNC 7 Report on Hypertension http://www.nhlbi.nih.gov/guidelines/hypertension/ Source: NHLBI

Internet Resources: DASH Diet for the Treatment of Hypertension http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/index.htm SLIDE INFORMATION SOURCE: Mosca L, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109:672-693. Source: Mosca 2004

Internet Resources: Diagnosis and Treatment of Diabetes http://www.diabetes.org SLIDE DIRECTS AUDIENCE TO: The American Diabetes Association website. Source: Mosca 2004

Internet Resources: American Heart Association Statement on Diabetes and Cardiovascular Disease http://circ.ahajournals.org/cgi/reprint/115/1/114 SLIDE DIRECTS AUDIENCE TO: Buse JB, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.Circulation. 2007 ;115:11.

Internet Resources: Absolute CHD Risk Calculation http://hp2010.nhlbihin.net/atpiii/calculator.asp

Conclusions Gender differences exist in diagnosis, treatment, and prognosis of CHD Knowledge of gender differences is essential for appropriate therapy Evidence-based guidelines provide a new framework for prevention and treatment of cardiovascular disease in women